ArticleFrontiers in psychiatry2026
Comorbidity network characteristics of depressive and anxiety symptoms and their associations with quality of life in patients with spinal cord injury: a cross-sectional study.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To examine the topological structure of the comorbidity network of depressive and anxiety symptoms in patients with subacute spinal cord injury (SCI), identify core and bridge symptoms, and explore the independent associations between specific symptoms and quality-of-life outcomes. Methods: A total of 316 patients with subacute SCI were assessed using the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7), and the World Health Organization Quality of Life Brief Version (WHOQOL-BREF). A Gaussian graphical model (GGM) was estimated to construct the depression-anxiety symptom network. Expected influence (EI) and bridge expected influence (bEI) were calculated to identify core and bridge nodes. Flow network analyses were performed to evaluate independent conditional associations between symptoms and quality-of-life outcomes. Network comparison tests (NCTs) were used to examine network invariance across key clinical subgroups. Ordinal PHQ-9 and GAD-7 items were handled using cor_auto-derived polychoric correlations where appropriate, and sensitivity analyses examined EBIC tuning, no-jitter estimation, data-driven communities, and covariate-adjusted flow networks. Results: Centrality analyses showed that guilt (PHQ.6, EI = 1.257), irritability (GAD.6, EI = 1.096), and psychomotor changes (PHQ.8, EI = 1.006) were among the most influential symptoms in the network, whereas depressed mood (PHQ.2, bEI = 1.241), concentration difficulties (PHQ.7, bEI = 0.972), irritability (GAD.6, bEI = 0.954), and psychomotor changes (PHQ.8, bEI = 0.942) showed the greatest bridge effects across the depression and anxiety communities. The strongest edges in the network were PHQ.9-PHQ.8 (weight = 0.396), PHQ.5-PHQ.4 (weight = 0.395), and PHQ.8-GAD.5 (weight = 0.384). Flow network analyses indicated that suicidal ideation, depressed mood, and restlessness were more strongly negatively associated with general health, whereas concentration difficulties and psychomotor changes were more strongly negatively associated with overall quality of life. NCT results showed no significant differences in network structure or global strength across sex or injury severity subgroups (P > 0.05). Bootstrap analyses supported acceptable network stability. All bivariate symptom-QOL correlations were negative after verification of scoring direction; positive symptom-QOL partial edges were therefore interpreted cautiously as conditional suppression effects rather than as evidence that symptoms were associated with better QOL. Conclusion: The depression-anxiety comorbidity network in patients with SCI appears to be organized around a limited number of highly influential symptoms, particularly guilt, irritability, and psychomotor abnormalities. Moving beyond total questionnaire scores, prioritizing symptoms with high centrality, strong bridge effects, and close links to quality-of-life outcomes may help refine psychological assessment and intervention planning in SCI rehabilitation. All edges should be interpreted as undirected conditional associations, not causal pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.